Is a Major Market Crash Looming? S&P 500 and Nasdaq React to Shocking GDP Growth—Find Out What This Means for Your Investments!

U.S. stocks experienced a rocky trading session on Tuesday, following the release of unexpectedly strong economic data. According to the Bureau of Economic Analysis, the U.S. economy grew at an annualized rate of 4.3% in the third quarter, significantly surpassing the expected 3.3%. This growth was buoyed by robust consumer spending over the summer, but it prompted investors to reassess their expectations regarding near-term interest-rate cuts from the Federal Reserve.

The major U.S. indices showed mixed performance: the blue-chip Dow Jones Industrial Average (^DJI) dipped by approximately 0.2%, while both the S&P 500 (^GSPC) and the tech-heavy Nasdaq Composite (^IXIC) hovered just above the flatline, each gaining less than 0.1%. This fluctuation came after a rally that saw stocks earn three consecutive wins to start the week.

In commodities, precious metals continued their impressive rally. Gold (GC=F) and silver (SI=F) extended their gains, positioning them for their best year in over four decades. Meanwhile, copper (HG=F) hit a record high, surpassing $12,000 per ton for the first time.

This economic update is particularly significant as it coincides with the holiday season, a time when consumer behavior can heavily influence the market. With consumer confidence set to be measured on Tuesday morning by the Conference Board, analysts are keenly observing how the data reflects the ongoing "K-shaped" economy. This term describes a divergence where higher-income households are maintaining spending levels, while lower-income families grapple with financial challenges.

Traders reacted swiftly to the GDP data, adjusting their bets on Federal Reserve interest-rate cuts. The probability of the Fed remaining steady in its interest rates during the January meeting now stands at 85%, an increase from 80% a day earlier and 75% last week. However, a significant number of wagers still anticipate two cuts by the end of next year, signaling ongoing uncertainty in the market.

Adding to the day's news, the pharmaceutical company Novo Nordisk (NVO) received official U.S. approval for its Wegovy weight-loss pill, causing its shares to jump in premarket trading. This approval marks a crucial moment for the Danish drugmaker, as it aims to regain lost ground against its U.S. rival, Eli Lilly (LLY), amid increasing competition in the weight-loss market.

Looking ahead, U.S. stock markets will have an early close on Wednesday and will be closed for the Christmas holiday on Thursday. As investors prepare for the break, the implications of the latest economic data will continue to reverberate through market dynamics, prompting further analysis and speculation surrounding consumer spending and interest rates into the new year.